Aided Cortical Auditory Evoked Potentials in Infants With Frequency-Specific Synthetic Speech Stimuli : Sensitivity, Repeatability, and Feasibility

Copyright © 2023 The Authors. Ear & Hearing is published on behalf of the American Auditory Society, by Wolters Kluwer Health, Inc..

OBJECTIVES: The cortical auditory evoked potential (CAEP) test is a candidate for supplementing clinical practice for infant hearing aid users and others who are not developmentally ready for behavioral testing. Sensitivity of the test for given sensation levels (SLs) has been reported to some degree, but further data are needed from large numbers of infants within the target age range, including repeat data where CAEPs were not detected initially. This study aims to assess sensitivity, repeatability, acceptability, and feasibility of CAEPs as a clinical measure of aided audibility in infants.

DESIGN: One hundred and three infant hearing aid users were recruited from 53 pediatric audiology centers across the UK. Infants underwent aided CAEP testing at age 3 to 7 months to a mid-frequency (MF) and (mid-)high-frequency (HF) synthetic speech stimulus. CAEP testing was repeated within 7 days. When developmentally ready (aged 7-21 months), the infants underwent aided behavioral hearing testing using the same stimuli, to estimate the decibel (dB) SL (i.e., level above threshold) of those stimuli when presented at the CAEP test sessions. Percentage of CAEP detections for different dB SLs are reported using an objective detection method (Hotellings T 2 ). Acceptability was assessed using caregiver interviews and a questionnaire, and feasibility by recording test duration and completion rate.

RESULTS: The overall sensitivity for a single CAEP test when the stimuli were ≥0 dB SL (i.e., audible) was 70% for the MF stimulus and 54% for the HF stimulus. After repeat testing, this increased to 84% and 72%, respectively. For SL >10 dB, the respective MF and HF test sensitivities were 80% and 60% for a single test, increasing to 94% and 79% for the two tests combined. Clinical feasibility was demonstrated by an excellent >99% completion rate, and acceptable median test duration of 24 minutes, including preparation time. Caregivers reported overall positive experiences of the test.

CONCLUSIONS: By addressing the clinical need to provide data in the target age group at different SLs, we have demonstrated that aided CAEP testing can supplement existing clinical practice when infants with hearing loss are not developmentally ready for traditional behavioral assessment. Repeat testing is valuable to increase test sensitivity. For clinical application, it is important to be aware of CAEP response variability in this age group.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:44

Enthalten in:

Ear and hearing - 44(2023), 5 vom: 26. Sept., Seite 1157-1172

Sprache:

Englisch

Beteiligte Personen:

Visram, Anisa S [VerfasserIn]
Stone, Michael A [VerfasserIn]
Purdy, Suzanne C [VerfasserIn]
Bell, Steven L [VerfasserIn]
Brooks, Jo [VerfasserIn]
Bruce, Iain A [VerfasserIn]
Chesnaye, Michael A [VerfasserIn]
Dillon, Harvey [VerfasserIn]
Harte, James M [VerfasserIn]
Hudson, Caroline L [VerfasserIn]
Laugesen, Søren [VerfasserIn]
Morgan, Rhiannon E [VerfasserIn]
O'Driscoll, Martin [VerfasserIn]
Roberts, Stephen A [VerfasserIn]
Roughley, Amber J [VerfasserIn]
Simpson, David [VerfasserIn]
Munro, Kevin J [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 02.11.2023

Date Revised 06.11.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1097/AUD.0000000000001352

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35524148X